Company / Revenue per Share
Zai Lab Ltd Revenue per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.43
FY2025
5-year range
$0.05 / $0.43
FY2021-FY2025
Trend
+4.0%
vs FY2024
Sector context
#118 of 154
Health Care
What the data says
Zai Lab Ltd's revenue per share of $0.43 is lower than 77% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 3 consecutive years, from $0.05 in FY2022 to $0.43 in FY2025.
Based on SEC 10-K filings.
0.43 in FY2025 with a 5-year CAGR of +195.6%.
Improved from $0.28 to $0.43 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +102.7%
- 5-Year CAGR
- +195.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 154This company $0.43 Sector average $15.09
▼
-97.2% below sector average
Key checks
Key Insights
- Zai Lab Ltd's revenue per share has grown for 3 consecutive years.
- In FY2025, revenue per share increased 4.0% year-over-year.
- Ranks #118 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.43 | +4.0% |
| FY2024 | $0.41 | +47.7% |
| FY2023 | $0.28 | +441.8% |
| FY2022 | $0.05 | -65.3% |
| FY2021 | $0.15 | +7722.1% |
| FY2020 | $0.00 | -99.1% |
| FY2019 | $0.20 | +8127.0% |
| FY2018 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026